Affimed NV (NasdaqGM:AFMD) (AFMD) Q2 2021 Earnings Call Transcript
AFMD earnings call for the period ending June 30, 2021.
Mindfully Curated
AFMD earnings call for the period ending June 30, 2021.
CNN sounds the alarm on marijuana’s risks to heart health.
There has been a major shakeup in the C-suite.
The company is seen as a short squeeze target on the popular subreddit WallStreetBets.
Hydrogen fuel cell electric vehicles are gaining attention. That’s both good and bad for Nikola.
Discussing Affirm’s latest partnership announcement and its 44% stock increase.
El Salvador is using Bitcoin as legal tender, but it’s exploring Algorand for other purposes.
The company could soon be airborne again.
A secondary offering spooked investors.
An unexpected regulatory setback weighed heavily on the biotech’s shares last month.
Paylocity reported a great quarter and provided strong forecasts for next year.
The growth stock is having trouble winning over new investors after taking a beating this year.
The notion that groups of individual investors can consistently organize efforts to push stock prices around is starting to crumble. At some point, companies must prove their stock’s value. And, at some point, people will want to take profits.
A great earnings report sent shares higher as growth stocks charged ahead.
DADA earnings call for the period ending June 30, 2021.
CASY earnings call for the period ending June 30, 2021.
There are a few news items affecting shares of the fintech specialist.
A minor announcement by the company sent its shares soaring.
Early investors can now sell their shares. But will they?
The company’s stock spiked after being added to the Nasdaq-100.